Global Robotic Endoscopy Devices Market, By Type (Standard Definition (SD) Visualization Systems, High Definition (HD) Visualization Systems, and Others), Product (Therapeutic, and Diagnostic), Application (Colonoscopy, Bronchoscopy, Laparoscopy, and Others), End Users (Ambulatory Surgical Centers, Hospitals, and Others), Technology (Immunoassay, PCR, NGS, Flow Cytometry, and Other Technologies), Indication (Lung Cancer, Colorectal Cancer, Melanoma, and Other Cancers) – Industry Trends and Forecast to 2031.
Robotic Endoscopy Devices Market Analysis and Size
The robotic endoscopy devices market is witnessing exponential growth fueled by the latest technological advancements. Innovations such as AI-enabled navigation, miniaturization, and enhanced imaging capabilities are revolutionizing diagnostic and surgical procedures. With a surge in demand for minimally invasive surgeries and improved patient outcomes, the market is poised for continuous expansion, promising a future where precision and efficiency redefine healthcare standards.
For instance, in March 2021, Asensus Surgical Inc. obtained FDA clearance for its senhance surgical system in the U.S. This robotic platform, cleared for general surgery, including endoscopy procedures, enhances surgical precision and control, promising advancements in minimally invasive interventions.
The global robotic endoscopy devices market size was valued at USD 2.18 billion in 2023, is projected to reach USD 6.50 billion by 2031, with a CAGR of 14.65% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Standard Definition (SD) Visualization Systems, High Definition (HD) Visualization Systems, and Others), Product (Therapeutic and Diagnostic), Application (Colonoscopy, Bronchoscopy, Laparoscopy, and Others), End Users (Ambulatory Surgical Centers, Hospitals, and Others), Technology (Immunoassay, PCR, NGS, Flow Cytometry, and Other Technologies), Indication (Lung Cancer, Colorectal Cancer, Melanoma, and Other Cancers)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Asensus Surgical US, Inc. (U.S.), Medical Device Business Services, Inc. (U.S.), KARL STORZ (Germany), Stryker (U.S.), Medtronic (Ireland), Brainlab AG (Germany), Smith + Nephew (U.K.), Intuitive Surgical Operations, Inc. (U.S.), EndoMaster Pte Ltd (Singapore), Boston Scientific Corporation (U.S.), Richard Wolf GmbH (Germany), FUJIFILM Holdings America Corporation (U.S.), HOYA Corporation. (Japan), Johnson & Johnson Services, Inc. (U.S.), B. Braun SE (Germany), Renishaw plc. (U.K.), Cook (U.S.), and Ovesco Endoscopy AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
Robotic endoscopy devices are advanced medical tools utilized for minimally invasive procedures within the body. Equipped with robotic arms and precise imaging systems, they enable surgeons to navigate and perform intricate tasks with enhanced skill and accuracy. These devices revolutionize procedures such as gastrointestinal examinations and surgeries by providing clearer visuals, better control, and reduced patient discomfort, ultimately improving medical outcomes.
Robotic Endoscopy Devices Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases such as gastrointestinal disorders, cancer, and cardiovascular diseases is fueling demand for robotic endoscopy devices worldwide. These devices offer advanced imaging and precision, facilitating early detection, accurate diagnosis, and minimally invasive treatment. For instance, in gastrointestinal endoscopy, robotic systems such as the Medrobotics Flex Robotic System enable surgeons to navigate complex anatomies with greater precision, enhancing patient outcomes and driving market growth.
- Expansion of Indications
The exploration of robotic endoscopy devices for a broader range of indications beyond traditional endoscopic procedures, such as surgeries in difficult-to-reach anatomical areas, is significantly driving market growth. For instance, these devices are increasingly used in minimally invasive surgeries for conditions such as colorectal cancer, enabling precise interventions in challenging anatomical locations. This expansion of applications enhances the market potential of robotic endoscopy devices by catering to a wider range of medical needs.
Opportunities
- Increasing Demand for Early Disease Detection
The growing emphasis on early disease detection, notably for cancer, is propelling the demand for robotic endoscopy devices with advanced imaging capabilities. These devices enable clinicians to detect lesions and abnormalities at earlier stages, leading to improved patient outcomes and reduced healthcare costs associated with late-stage treatments. For instance, advanced robotic endoscopes equipped with high-definition imaging and AI algorithms enhance the detection of precancerous lesions in the gastrointestinal tract, aiding in timely intervention and prevention strategies.
- Rising Demand for Minimally Invasive Procedures
Robotic endoscopy devices are revolutionizing medical procedures by enabling minimally invasive interventions, significantly reducing patient discomfort, recovery periods, and hospital stays. This advancement is driving widespread adoption among both patients and healthcare providers. For instance, the use of robotic-assisted endoscopic surgeries for conditions such as colorectal cancer allows for precise, less invasive procedures, leading to quicker recovery times and improved patient outcomes, ultimately propelling market growth.
Restraints/Challenges
- High Initial Investment
The high initial investment required for developing and implementing robotic endoscopy devices poses a significant barrier to adoption, especially for smaller healthcare facilities or regions with limited resources. Financial constraints limit market penetration and access to advanced endoscopic technologies, potentially impeding patient care and innovation in medical procedures.
- Lack of Reimbursement Policies
Limited reimbursement policies and coverage restrictions from insurance companies create financial barriers for healthcare facilities considering investments in robotic endoscopy devices. This impediment stifles market growth as facilities hesitate to invest resources without guarantee of sufficient reimbursement, delaying the integration of advanced technologies into clinical practice.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In January 2024, AnX Robotica's NaviCam ProScan, an AI-assisted endoscopy tool, received de novo clearance from the FDA. This advancement signifies a significant step forward in leveraging AI for enhanced medical diagnostics during endoscopic procedures, promising improved accuracy and efficiency in detecting abnormalities
- In October 2023, Olympus Corporation launched the EVIS X1 endoscopy system, representing the latest evolution in endoscopic technology. With advanced features and capabilities, this system offers healthcare professionals cutting-edge tools for visualization and diagnosis, potentially improving patient outcomes and procedural efficiency
- In June 2023, PENTAX Medical introduced the Aqua TYPHOON, a brushless solution for automated pre-cleaning of endoscopes. This innovation streamlines the reprocessing workflow by eliminating the need for manual pre-cleaning, enhancing efficiency, and reducing the risk of cross-contamination. It marks a significant advancement in endoscope reprocessing practices, promoting sustainability and infection prevention
- In September 2021, FUJIFILM Holdings Corporation unveiled a new software version of "CAD EYE", leveraging AI technology for real-time detection of colonic polyps during colonoscopy. This update integrates deep learning algorithms, enhancing the accuracy and efficacy of polyp detection and characterization, ultimately improving diagnostic capabilities and patient care during colonoscopic examinations
Robotic Endoscopy Devices Market Scope
The market is segmented on the basis of type, product, application, technology, indication, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Standard Definition (SD) Visualization Systems
- High Definition (HD) Visualization Systems
- Others
Product
- Therapeutic
- Diagnostic
Application
- Colonoscopy
- Bronchoscopy
- Laparoscopy
- Others
End Users
- Ambulatory Surgical Centers
- Hospitals
- Others
Technology
- Immunoassay
- PCR
- NGS
- Flow Cytometry
- Other Technologies
Indication
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Other Cancers
Robotic Endoscopy Devices Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, product, application, technology, indication, and end users as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
Asia-Pacific is expected to show significant growth in the market due to the rapidly increasing disposable income, healthcare expenditure, and prevalence of chronic diseases in the region. These factors drive demand for advanced medical technologies, fostering market expansion and innovation in endoscopic procedures.
North America is expected to dominate the market due to its robust healthcare sector and hospitals' economic capability to invest in such technology. The region's well-established infrastructure fosters widespread adoption, driving advancements and innovations in robotic endoscopy for improved patient care.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Robotic Endoscopy Devices Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Asensus Surgical US, Inc. (U.S.)
- Medical Device Business Services, Inc. (U.S.)
- KARL STORZ (Germany)
- Stryker (U.S.)
- Medtronic (Ireland)
- Brainlab AG (Germany)
- Smith + Nephew (U.K.)
- Intuitive Surgical Operations, Inc. (U.S.)
- EndoMaster Pte Ltd (Singapore)
- Boston Scientific Corporation (U.S.)
- Richard Wolf GmbH (Germany)
- FUJIFILM Holdings America Corporation (U.S.)
- HOYA Corporation. (Japan)
- Johnson & Johnson Services, Inc. (U.S.)
- B. Braun SE (Germany)
- Renishaw plc. (U.K.)
- Cook (U.S.)
- Ovesco Endoscopy AG (Germany)
SKU-